Vascular Risk Factors and Cognitive Impairment in Chronic Kidney Disease
Authors:
- Manjula Kurella TamuraMTManjula Kurella Tamura
- Dawei XieDXDawei Xie
- Kristine YaffeKYKristine Yaffe
- Debbie L. CohenDCDebbie L. Cohen
- Valerie TealVTValerie Teal
- Scott E. KasnerSKScott E. Kasner
- Steven R. MesséSMSteven R. Messé
- Ashwini R. SehgalASAshwini R. Sehgal
- John KusekJKJohn Kusek
- Karen B. DeSalvoKDKaren B. DeSalvo
- Denise Cornish-ZirkerDCDenise Cornish-Zirker
- Janet CohanJCJanet Cohan
- 1 February 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 6 (2) , 248-256
Abstract
Summary: Background and objectives: Cognitive impairment is common among persons with chronic kidney disease, but the extent to which nontraditional vascular risk factors mediate this association is unclear. Design, setting, participants, & measurements: We conducted cross-sectional analyses of baseline data collected from adults with chronic kidney disease participating in the Chronic Renal Insufficiency Cohort study. Cognitive impairment was defined as a Modified Mini-Mental State Exam score >1 SD below the mean score. Results: Among 3591 participants, the mean age was 58.2 ± 11.0 years, and the mean estimated GFR (eGFR) was 43.4 ± 13.5 ml/min per 1.73 m2. Cognitive impairment was present in 13%. After adjustment for demographic characteristics, prevalent vascular disease (stroke, coronary artery disease, and peripheral arterial disease) and traditional vascular risk factors (diabetes, hypertension, smoking, and elevated cholesterol), an eGFR 2 was associated with a 47% increased odds of cognitive impairment (odds ratio 1.47, 95% confidence interval 1.05, 2.05) relative to those with an eGFR 45 to 59 ml/min per 1.73 m2. This association was attenuated and no longer significant after adjustment for hemoglobin concentration. While other nontraditional vascular risk factors including C-reactive protein, homocysteine, serum albumin, and albuminuria were correlated with cognitive impairment in unadjusted analyses, they were not significantly associated with cognitive impairment after adjustment for eGFR and other confounders. Conclusions: The prevalence of cognitive impairment was higher among those with lower eGFR, independent of traditional vascular risk factors. This association may be explained in part by anemia.Keywords
This publication has 36 references indexed in Scilit:
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney DiseaseNew England Journal of Medicine, 2009
- Albuminuria, Cognitive Functioning, and White Matter Hyperintensities in Homebound EldersAmerican Journal of Kidney Diseases, 2009
- Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk FactorsDiabetes Care, 2009
- Kidney Function and Cognitive Performance and Decline in Older MenJournal of the American Geriatrics Society, 2008
- Anemia and Cerebral Outcomes: Many Questions, Fewer AnswersAnesthesia & Analgesia, 2008
- Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) StudyAmerican Journal of Kidney Diseases, 2008
- Albuminuria and Dementia in the Elderly: A Community StudyAmerican Journal of Kidney Diseases, 2008
- Microalbuminuria, peripheral artery disease, and cognitive functionKidney International, 2008
- Kidney Function Is Related to Cerebral Small Vessel DiseaseStroke, 2008
- Risk Factors for Dementia in the Cardiovascular Health Cognition StudyNeuroepidemiology, 2003